Ning Xu

42PUBLICATIONS
50CO-AUTHORS
PharmacogenomicsCharacterisation of biological macromoleculesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|May 26, 2026
Design, Preclinical Evaluation, and Clinical Translation of [68Ga]Ga/[177Lu]Lu-JH120061, A Novel Radiopharmaceutical Targeting CXCR4.

|Apr 10, 2026
USP2 Attenuates Spermatogenic Cell Apoptosis Via PINK1/Parkin-Dependent Mitophagy in Varicocoele: A Functional Study.

Rui-Jie Yao, Hong Xiao, Jun-Hang Zheng

|Mar 20, 2026
A feedback mechanism from prostate cancer cells to macrophages, reinforced by STAT1, regulates tumor progression and resistance to radiotherapy.

Jia-Yin Chen, Yu-Ting Xue, Bin Lin

|Jan 26, 2026
Computed tomography radiomics-derived nomogram for prediciting early renal function decline after partial nephrectomy in renal cell carcinoma: a multicenter development/validation study.

Shao-Hao Chen, Xiao-Hui Wu, Cheng-Long Zeng

|Jan 06, 2026
Response to Comments on "Pretreatment [⁶⁸Ga]-PSMA-11 PET/CT to Predict the Response to Treatment With Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma".

Shao-Hao Chen, Xiao-Hui Wu, Qian-Ren-Shun Qiu

|Dec 02, 2025
Super-enhancers mediates SLC7A11 via FOXA1 to regulate disulfidptosis in prostate cancer.

Zhen Kang, Bin Lin, Zhi-Bin Ke

Pageof 7

Frequent Collaborators

27 joint publications

Xueyi Xue

18 joint publications

Yong Wei

7 joint publications

Shaohao Chen

6 joint publications

Qingshui Zheng